Citation Impact
Citing Papers
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma
2019
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Cancer immunotherapy beyond immune checkpoint inhibitors
2018
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Fabrication and biocompatibility of a porous bioglass ceramic in a Na 2 OCaOSiO 2 P 2 O 5 system
1991
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Bound phenolics in foods, a review
2013 Standout
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Cytokines in CAR T Cell–Associated Neurotoxicity
2020
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
CAR-T cells: the long and winding road to solid tumors
2018
Engineered T Cell Therapy for Cancer in the Clinic
2019
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
2020
Clinical lessons learned from the first leg of the CAR T cell journey
2019
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
2020
Genetic engineering of T cells for immunotherapy
2021
Macrophages in immunoregulation and therapeutics
2023 Standout
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
2020
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Genetically engineered T cells for cancer immunotherapy
2019
Delivery technologies for cancer immunotherapy
2019 Standout
Recent updates on CAR T clinical trials for multiple myeloma
2019
Effect of extraction solvent on total phenol content, total flavonoid content, and antioxidant activity of Limnophila aromatica
2013 Standout
Targeting tumor-associated macrophages to synergize tumor immunotherapy
2021
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
2020
Programmable synthetic receptors: the next-generation of cell and gene therapies
2024
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy
2015
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
De novo design of tyrosine and serine kinase-driven protein switches
2021 StandoutNobel
Changes in nutritional and bio-functional compounds and antioxidant capacity during black garlic processing
2017
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
2020 Standout
Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients
2021
CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
2022
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Antioxidant activities and total phenolic contents of various extracts from defatted wheat germ
2010
Direct Evidence for Hydroxyl Radical Scavenging Activity of Cerium Oxide Nanoparticles
2011
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Nonviral RNA chimeric antigen receptor–modified T cells in patients with Hodgkin lymphoma
2018
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
2020 Science
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
2018
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Antibodies to watch in 2019
2018
Chimeric Antigen Receptor Therapy
2018 Standout
Free and Bound Phenolic Acids and Total Phenolics in Black, Blue, and Yellow Barley and Their Contribution to Free Radical Scavenging Capacity
2012
Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)
2019 Standout
Evaluation of the Use of Different Solvents for Phytochemical Constituents, Antioxidants, and In Vitro Anti-Inflammatory Activities of Severinia buxifolia
2019 Standout
Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants
1998 Standout
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Works of Qingming Yang being referenced
Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial
2016
Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers
2017
Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma
2017
Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
2019
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
2020
Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report
2016
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells
2016
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B cell lymphoma
2020
Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial
2020
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
2021
[Hepatitis B virus reactivation induced by Brentuximab vedotin in the treatment of Hodgkin lymphoma: a case report and literature review].
2014
Autologous T cells expressing CD30 chimeric antigen receptors for relapsed or refractory Hodgkin's lymphoma: an open-label phase 1 trial
2015
CD133-redirected chimeric antigen receptor engineered autologous T-cell treatment in patients with advanced and metastatic malignancies.
2017
Antioxidant activities of malt extract from barley (Hordeum vulgare L.) toward various oxidative stress in vitro and in vivo
2009
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
2018
Safety and efficacy of decitabine-primed anti-PD-1 (SHR-1210) treatment in patients with relapsed/refractory classical Hodgkin lymphoma.
2018
Preparation of phosphate glass composite and their prosthetic applications
1982